Furthermore, inhibition of the expression of c−Myc by small molecule inhibitors can inhibit the proliferation of mouse and human T-ALL cells, suggesting that c−Myc may be the proto-oncogene that drives T-ALL and is regulated by FBW7 (14). This evidence concerns the gene MYC and acute lymphoblastic leukemia.